- Home
- QSI vs GNFT Comparison
QSI vs GNFT Comparison
Compare QSI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- GNFT
- Stock Information
- Founded
- QSI 2013
- GNFT 1999
- Country
- QSI United States
- GNFT France
- Employees
- QSI N/A
- GNFT N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QSI Health Care
- GNFT Health Care
- Exchange
- QSI Nasdaq
- GNFT Nasdaq
- Market Cap
- QSI 226.8M
- GNFT 216.7M
- IPO Year
- QSI N/A
- GNFT 2019
- Fundamental
- Price
- QSI $1.73
- GNFT $4.32
- Analyst Decision
- QSI Strong Buy
- GNFT Strong Buy
- Analyst Count
- QSI 3
- GNFT 2
- Target Price
- QSI $2.38
- GNFT $10.00
- AVG Volume (30 Days)
- QSI 13.4M
- GNFT 10.1K
- Earning Date
- QSI 11-11-2025
- GNFT 09-22-2025
- Dividend Yield
- QSI N/A
- GNFT N/A
- EPS Growth
- QSI N/A
- GNFT N/A
- EPS
- QSI N/A
- GNFT N/A
- Revenue
- QSI $3,412,000.00
- GNFT $52,994,715.00
- Revenue This Year
- QSI N/A
- GNFT $3.14
- Revenue Next Year
- QSI $219.33
- GNFT N/A
- P/E Ratio
- QSI N/A
- GNFT N/A
- Revenue Growth
- QSI 100.47
- GNFT N/A
- 52 Week Low
- QSI $0.61
- GNFT $2.55
- 52 Week High
- QSI $5.77
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- QSI 61.95
- GNFT 59.71
- Support Level
- QSI $1.44
- GNFT $3.87
- Resistance Level
- QSI $1.92
- GNFT $4.10
- Average True Range (ATR)
- QSI 0.16
- GNFT 0.20
- MACD
- QSI 0.03
- GNFT 0.04
- Stochastic Oscillator
- QSI 64.91
- GNFT 86.15
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.